A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Por Wischnik Arthur, Schmidt Marcus, Neise Michael, Nusch Arnd, Fett Werner, Huober Jens, Gerhardt Steffen, Goehler Thomas, Lück Hans-Joachim, Rost Andreas
Publicado em 2010-01-01

A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer

Por Huober, Jens, Fett, Werner, Nusch, Arnd, Neise, Michael, Schmidt, Marcus, Wischnik, Arthur, Gerhardt, Steffen, Goehler, Thomas, Lück, Hans-Joachim, Rost, Andreas
Publicado em 2010

Trastuzumab in Human Epidermal Growth Factor Receptor 2‐Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 i...

Por Dall, Peter, Koch, Thorsten, Göhler, Thomas, Selbach, Johannes, Ammon, Andreas, Eggert, Jochen, Gazawi, Nidal, Rezek, Daniela, Wischnik, Arthur, Hielscher, Carsten, Keitel, Stella, Cirrincione, Ursula, Hinke, Axel, Feisel‐Schwickardi, Gabriele
Publicado no Oncologist (2017)

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

Por Schönherr, Alexandra, Aivazova-Fuchs, Viktoria, Annecke, Katja, Jückstock, Julia, Hepp, Philip, Andergassen, Ulrich, Augustin, Doris, Simon, Wolfgang, Wischnik, Arthur, Mohrmann, Svjetlana, Salmen, Jessica, Zwingers, Thomas, Kiechle, Marion, Harbeck, Nadja, Friese, Klaus, Janni, Wolfgang, Rack, Brigitte
Publicado em 2012